10-(4-tert-butylphenyl)-3-pyridin-2-yl-4H-phenoxazin-4-ide;2-(2H-dibenzo-p-dioxin-2-id-1-yl)pyridine;1,3-dicyclohexylprop-1-ene-1,3-diol;2-(9,9-dimethyl-2H-xanthen-2-id-1-yl)pyridine;2-(9,9-dimethyl-3H-xanthen-3-id-2-yl)pyridine;bis(1,3-diphenylprop-1-ene-1,3-diol);tetrakis(iridium);2,2,6,6-tetramethylhept-3-ene-3,5-diol

C140H141Ir4N5O13-4 — CID 162274794

IUPAC10-(4-tert-butylphenyl)-3-pyridin-2-yl-4H-phenoxazin-4-ide;2-(2H-dibenzo-p-dioxin-2-id-1-yl)pyridine;1,3-dicyclohexylprop-1-ene-1,3-diol;2-(9,9-dimethyl-2H-xanthen-2-id-1-yl)pyridine;2-(9,9-dimethyl-3H-xanthen-3-id-2-yl)pyridine;bis(1,3-diphenylprop-1-ene-1,3-diol);tetrakis(iridium);2,2,6,6-tetramethylhept-3-ene-3,5-diol
SMILESCC(C)(C)C(O)=CC(O)C(C)(C)C.CC(C)(C)c1ccc(N2c3ccc(-c4ccccn4)[c-]c3Oc3ccccc32)cc1.CC1(C)c2ccccc2Oc2c[c-]c(-c3ccccn3)cc21.CC1(C)c2ccccc2Oc2cc[c-]c(-c3ccccn3)c21.OC(=CC(O)C1CCCCC1)C1CCCCC1.OC(=CC(O)c1ccccc1)c1ccccc1.OC(=CC(O)c1ccccc1)c1ccccc1.[Ir].[Ir].[Ir].[Ir].[c-]1ccc2c(c1-c1ccccn1)Oc1ccccc1O2
InChIInChI=1S/C27H23N2O.2C20H16NO.C17H10NO2.C15H26O2.2C15H14O2.C11H22O2.4Ir/c1-27(2,3)20-12-14-21(15-13-20)29-23-9-4-5-10-25(23)30-26-18-19(11-16-24(26)29)22-8-6-7-17-28-22;1-20(2)15-9-3-4-11-17(15)22-18-12-7-8-14(19(18)20)16-10-5-6-13-21-16;1-20(2)15-7-3-4-9-18(15)22-19-11-10-14(13-16(19)20)17-8-5-6-12-21-17;1-2-9-15-14(8-1)19-16-10-5-6-12(17(16)20-15)13-7-3-4-11-18-13;3*16-14(12-7-3-1-4-8-12)11-15(17)13-9-5-2-6-10-13;1-10(2,3)8(12)7-9(13)11(4,5)6;;;;/h4-17H,1-3H3;3-7,9-13H,1-2H3;3-9,11-13H,1-2H3;1-5,7-11H;11-14,16-17H,1-10H2;2*1-11,14,16-17H;7-8,12-13H,1-6H3;;;;/q4*-1;;;;;;;;
InChIKeyNNKUKXWDSBQXSU-UHFFFAOYSA-N
MW2870.56 g/mol
LogP35.29
Rot. Bonds15

About 10-(4-tert-butylphenyl)-3-pyridin-2-yl-4H-phenoxazin-4-ide;2-(2H-dibenzo-p-dioxin-2-id-1-yl)pyridine;1,3-dicyclohexylprop-1-ene-1,3-diol;2-(9,9-dimethyl-2H-xanthen-2-id-1-yl)pyridine;2-(9,9-dimethyl-3H-xanthen-3-id-2-yl)pyridine;bis(1,3-diphenylprop-1-ene-1,3-diol);tetrakis(iridium);2,2,6,6-tetramethylhept-3-ene-3,5-diol

10-(4-tert-butylphenyl)-3-pyridin-2-yl-4H-phenoxazin-4-ide;2-(2H-dibenzo-p-dioxin-2-id-1-yl)pyridine;1,3-dicyclohexylprop-1-ene-1,3-diol;2-(9,9-dimethyl-2H-xanthen-2-id-1-yl)pyridine;2-(9,9-dimethyl-3H-xanthen-3-id-2-yl)pyridine;bis(1,3-diphenylprop-1-ene-1,3-diol);tetrakis(iridium);2,2,6,6-tetramethylhept-3-ene-3,5-diol (PubChem CID 162274794) has the molecular formula C140H141Ir4N5O13-4 and a molecular weight of 2870.56 g/mol. Its IUPAC name is 10-(4-tert-butylphenyl)-3-pyridin-2-yl-4H-phenoxazin-4-ide;2-(2H-dibenzo-p-dioxin-2-id-1-yl)pyridine;1,3-dicyclohexylprop-1-ene-1,3-diol;2-(9,9-dimethyl-2H-xanthen-2-id-1-yl)pyridine;2-(9,9-dimethyl-3H-xanthen-3-id-2-yl)pyridine;bis(1,3-diphenylprop-1-ene-1,3-diol);tetrakis(iridium);2,2,6,6-tetramethylhept-3-ene-3,5-diol.

Molecular Properties

Compound Name10-(4-tert-butylphenyl)-3-pyridin-2-yl-4H-phenoxazin-4-ide;2-(2H-dibenzo-p-dioxin-2-id-1-yl)pyridine;1,3-dicyclohexylprop-1-ene-1,3-diol;2-(9,9-dimethyl-2H-xanthen-2-id-1-yl)pyridine;2-(9,9-dimethyl-3H-xanthen-3-id-2-yl)pyridine;bis(1,3-diphenylprop-1-ene-1,3-diol);tetrakis(iridium);2,2,6,6-tetramethylhept-3-ene-3,5-diol
PubChem CID162274794
Molecular FormulaC140H141Ir4N5O13-4
Molecular Weight2870.56 g/mol
Exact Mass2871.91
IUPAC Name10-(4-tert-butylphenyl)-3-pyridin-2-yl-4H-phenoxazin-4-ide;2-(2H-dibenzo-p-dioxin-2-id-1-yl)pyridine;1,3-dicyclohexylprop-1-ene-1,3-diol;2-(9,9-dimethyl-2H-xanthen-2-id-1-yl)pyridine;2-(9,9-dimethyl-3H-xanthen-3-id-2-yl)pyridine;bis(1,3-diphenylprop-1-ene-1,3-diol);tetrakis(iridium);2,2,6,6-tetramethylhept-3-ene-3,5-diol
SMILESCC(C)(C)C(O)=CC(O)C(C)(C)C.CC(C)(C)c1ccc(N2c3ccc(-c4ccccn4)[c-]c3Oc3ccccc32)cc1.CC1(C)c2ccccc2Oc2c[c-]c(-c3ccccn3)cc21.CC1(C)c2ccccc2Oc2cc[c-]c(-c3ccccn3)c21.OC(=CC(O)C1CCCCC1)C1CCCCC1.OC(=CC(O)c1ccccc1)c1ccccc1.OC(=CC(O)c1ccccc1)c1ccccc1.[Ir].[Ir].[Ir].[Ir].[c-]1ccc2c(c1-c1ccccn1)Oc1ccccc1O2
InChIInChI=1S/C27H23N2O.2C20H16NO.C17H10NO2.C15H26O2.2C15H14O2.C11H22O2.4Ir/c1-27(2,3)20-12-14-21(15-13-20)29-23-9-4-5-10-25(23)30-26-18-19(11-16-24(26)29)22-8-6-7-17-28-22;1-20(2)15-9-3-4-11-17(15)22-18-12-7-8-14(19(18)20)16-10-5-6-13-21-16;1-20(2)15-7-3-4-9-18(15)22-19-11-10-14(13-16(19)20)17-8-5-6-12-21-17;1-2-9-15-14(8-1)19-16-10-5-6-12(17(16)20-15)13-7-3-4-11-18-13;3*16-14(12-7-3-1-4-8-12)11-15(17)13-9-5-2-6-10-13;1-10(2,3)8(12)7-9(13)11(4,5)6;;;;/h4-17H,1-3H3;3-7,9-13H,1-2H3;3-9,11-13H,1-2H3;1-5,7-11H;11-14,16-17H,1-10H2;2*1-11,14,16-17H;7-8,12-13H,1-6H3;;;;/q4*-1;;;;;;;;
InChIKeyNNKUKXWDSBQXSU-UHFFFAOYSA-N
XLogP35.29
TPSA262.79 Ų
H-Bond Donors8
H-Bond Acceptors18
Rotatable Bonds15
Heavy Atoms162
Complexity

Lipinski Rule of Five

4 violations

RuleValue
MW ≤ 5002870.56
LogP ≤ 535.29
H-Bond Donors ≤ 58
H-Bond Acceptors ≤ 1018

Computed Properties (RDKit)

Structural Alerts{'alert_name': 'acyclic_C=C-O', 'substructure': 'N/A'}, {'alert_name': 'Carbo_cation/anion', 'substructure': 'N/A'}

Analyze 10-(4-tert-butylphenyl)-3-pyridin-2-yl-4H-phenoxazin-4-ide;2-(2H-dibenzo-p-dioxin-2-id-1-yl)pyridine;1,3-dicyclohexylprop-1-ene-1,3-diol;2-(9,9-dimethyl-2H-xanthen-2-id-1-yl)pyridine;2-(9,9-dimethyl-3H-xanthen-3-id-2-yl)pyridine;bis(1,3-diphenylprop-1-ene-1,3-diol);tetrakis(iridium);2,2,6,6-tetramethylhept-3-ene-3,5-diol with MolForge

Explore ADMET properties, 3D molecular structure, drug-likeness score, and discover similar compounds using our AI-powered platform.

Launch Full Analysis

Related Compounds

Frequently Asked Questions

What is the IUPAC name of 10-(4-tert-butylphenyl)-3-pyridin-2-yl-4H-phenoxazin-4-ide;2-(2H-dibenzo-p-dioxin-2-id-1-yl)pyridine;1,3-dicyclohexylprop-1-ene-1,3-diol;2-(9,9-dimethyl-2H-xanthen-2-id-1-yl)pyridine;2-(9,9-dimethyl-3H-xanthen-3-id-2-yl)pyridine;bis(1,3-diphenylprop-1-ene-1,3-diol);tetrakis(iridium);2,2,6,6-tetramethylhept-3-ene-3,5-diol?
The IUPAC name of 10-(4-tert-butylphenyl)-3-pyridin-2-yl-4H-phenoxazin-4-ide;2-(2H-dibenzo-p-dioxin-2-id-1-yl)pyridine;1,3-dicyclohexylprop-1-ene-1,3-diol;2-(9,9-dimethyl-2H-xanthen-2-id-1-yl)pyridine;2-(9,9-dimethyl-3H-xanthen-3-id-2-yl)pyridine;bis(1,3-diphenylprop-1-ene-1,3-diol);tetrakis(iridium);2,2,6,6-tetramethylhept-3-ene-3,5-diol (CID 162274794) is 10-(4-tert-butylphenyl)-3-pyridin-2-yl-4H-phenoxazin-4-ide;2-(2H-dibenzo-p-dioxin-2-id-1-yl)pyridine;1,3-dicyclohexylprop-1-ene-1,3-diol;2-(9,9-dimethyl-2H-xanthen-2-id-1-yl)pyridine;2-(9,9-dimethyl-3H-xanthen-3-id-2-yl)pyridine;bis(1,3-diphenylprop-1-ene-1,3-diol);tetrakis(iridium);2,2,6,6-tetramethylhept-3-ene-3,5-diol.
What is the SMILES notation for 10-(4-tert-butylphenyl)-3-pyridin-2-yl-4H-phenoxazin-4-ide;2-(2H-dibenzo-p-dioxin-2-id-1-yl)pyridine;1,3-dicyclohexylprop-1-ene-1,3-diol;2-(9,9-dimethyl-2H-xanthen-2-id-1-yl)pyridine;2-(9,9-dimethyl-3H-xanthen-3-id-2-yl)pyridine;bis(1,3-diphenylprop-1-ene-1,3-diol);tetrakis(iridium);2,2,6,6-tetramethylhept-3-ene-3,5-diol?
The canonical SMILES for 10-(4-tert-butylphenyl)-3-pyridin-2-yl-4H-phenoxazin-4-ide;2-(2H-dibenzo-p-dioxin-2-id-1-yl)pyridine;1,3-dicyclohexylprop-1-ene-1,3-diol;2-(9,9-dimethyl-2H-xanthen-2-id-1-yl)pyridine;2-(9,9-dimethyl-3H-xanthen-3-id-2-yl)pyridine;bis(1,3-diphenylprop-1-ene-1,3-diol);tetrakis(iridium);2,2,6,6-tetramethylhept-3-ene-3,5-diol is CC(C)(C)C(O)=CC(O)C(C)(C)C.CC(C)(C)c1ccc(N2c3ccc(-c4ccccn4)[c-]c3Oc3ccccc32)cc1.CC1(C)c2ccccc2Oc2c[c-]c(-c3ccccn3)cc21.CC1(C)c2ccccc2Oc2cc[c-]c(-c3ccccn3)c21.OC(=CC(O)C1CCCCC1)C1CCCCC1.OC(=CC(O)c1ccccc1)c1ccccc1.OC(=CC(O)c1ccccc1)c1ccccc1.[Ir].[Ir].[Ir].[Ir].[c-]1ccc2c(c1-c1ccccn1)Oc1ccccc1O2.
What is the InChIKey of 10-(4-tert-butylphenyl)-3-pyridin-2-yl-4H-phenoxazin-4-ide;2-(2H-dibenzo-p-dioxin-2-id-1-yl)pyridine;1,3-dicyclohexylprop-1-ene-1,3-diol;2-(9,9-dimethyl-2H-xanthen-2-id-1-yl)pyridine;2-(9,9-dimethyl-3H-xanthen-3-id-2-yl)pyridine;bis(1,3-diphenylprop-1-ene-1,3-diol);tetrakis(iridium);2,2,6,6-tetramethylhept-3-ene-3,5-diol?
The InChIKey is NNKUKXWDSBQXSU-UHFFFAOYSA-N. The full InChI is InChI=1S/C27H23N2O.2C20H16NO.C17H10NO2.C15H26O2.2C15H14O2.C11H22O2.4Ir/c1-27(2,3)20-12-14-21(15-13-20)29-23-9-4-5-10-25(23)30-26-18-19(11-16-24(26)29)22-8-6-7-17-28-22;1-20(2)15-9-3-4-11-17(15)22-18-12-7-8-14(19(18)20)16-10-5-6-13-21-16;1-20(2)15-7-3-4-9-18(15)22-19-11-10-14(13-16(19)20)17-8-5-6-12-21-17;1-2-9-15-14(8-1)19-16-10-5-6-12(17(16)20-15)13-7-3-4-11-18-13;3*16-14(12-7-3-1-4-8-12)11-15(17)13-9-5-2-6-10-13;1-10(2,3)8(12)7-9(13)11(4,5)6;;;;/h4-17H,1-3H3;3-7,9-13H,1-2H3;3-9,11-13H,1-2H3;1-5,7-11H;11-14,16-17H,1-10H2;2*1-11,14,16-17H;7-8,12-13H,1-6H3;;;;/q4*-1;;;;;;;;.
What are the key properties of 10-(4-tert-butylphenyl)-3-pyridin-2-yl-4H-phenoxazin-4-ide;2-(2H-dibenzo-p-dioxin-2-id-1-yl)pyridine;1,3-dicyclohexylprop-1-ene-1,3-diol;2-(9,9-dimethyl-2H-xanthen-2-id-1-yl)pyridine;2-(9,9-dimethyl-3H-xanthen-3-id-2-yl)pyridine;bis(1,3-diphenylprop-1-ene-1,3-diol);tetrakis(iridium);2,2,6,6-tetramethylhept-3-ene-3,5-diol?
10-(4-tert-butylphenyl)-3-pyridin-2-yl-4H-phenoxazin-4-ide;2-(2H-dibenzo-p-dioxin-2-id-1-yl)pyridine;1,3-dicyclohexylprop-1-ene-1,3-diol;2-(9,9-dimethyl-2H-xanthen-2-id-1-yl)pyridine;2-(9,9-dimethyl-3H-xanthen-3-id-2-yl)pyridine;bis(1,3-diphenylprop-1-ene-1,3-diol);tetrakis(iridium);2,2,6,6-tetramethylhept-3-ene-3,5-diol has a molecular weight of 2870.56 g/mol, XLogP of 35.29, 15 rotatable bonds, 8 hydrogen bond donors, and 18 hydrogen bond acceptors.
Where does this data come from?
All data for 10-(4-tert-butylphenyl)-3-pyridin-2-yl-4H-phenoxazin-4-ide;2-(2H-dibenzo-p-dioxin-2-id-1-yl)pyridine;1,3-dicyclohexylprop-1-ene-1,3-diol;2-(9,9-dimethyl-2H-xanthen-2-id-1-yl)pyridine;2-(9,9-dimethyl-3H-xanthen-3-id-2-yl)pyridine;bis(1,3-diphenylprop-1-ene-1,3-diol);tetrakis(iridium);2,2,6,6-tetramethylhept-3-ene-3,5-diol is sourced from PubChem (CID 162274794), the world's largest open chemistry database maintained by the National Library of Medicine (NIH).